AI assistant
DEXCOM INC — Director's Dealing 2025
Nov 17, 2025
30198_dirs_2025-11-17_53570040-9f0f-4a00-8572-d8b6cf0bbdf7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2025-11-14
Reporting Person: Collins Richard Alexander (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-14 | Common Stock | S | 2906 | $59.05 | Disposed | 35088 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5074 | Direct |
Footnotes
F1: On August 7, 2025, the Richard A. Collins Revocable Trust (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth
above were sold pursuant to the 10b5-1 Plan.
F2: Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee.
F3: Represents unvested restricted stock units which were granted on May 8, 2025 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.